A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
Standard
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. / Karschnia, Philipp; Smits, Marion; Reifenberger, Guido; Le Rhun, Emilie; Ellingson, Benjamin M; Galldiks, Norbert; Kim, Michelle M; Huse, Jason T; Schnell, Oliver; Harter, Patrick N; Mohme, Malte; von Baumgarten, Louisa; Albert, Nathalie L; Huang, Raymond Y; Mehta, Minesh P; van den Bent, Martin; Weller, Michael; Vogelbaum, Michael A; Chang, Susan M; Berger, Mitchel S; Tonn, Joerg-Christian; Expert Rater Panel.
in: LANCET ONCOL, Jahrgang 24, Nr. 11, 11.2023, S. e438-e450.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
AU - Karschnia, Philipp
AU - Smits, Marion
AU - Reifenberger, Guido
AU - Le Rhun, Emilie
AU - Ellingson, Benjamin M
AU - Galldiks, Norbert
AU - Kim, Michelle M
AU - Huse, Jason T
AU - Schnell, Oliver
AU - Harter, Patrick N
AU - Mohme, Malte
AU - von Baumgarten, Louisa
AU - Albert, Nathalie L
AU - Huang, Raymond Y
AU - Mehta, Minesh P
AU - van den Bent, Martin
AU - Weller, Michael
AU - Vogelbaum, Michael A
AU - Chang, Susan M
AU - Berger, Mitchel S
AU - Tonn, Joerg-Christian
AU - Expert Rater Panel
N1 - Copyright © 2023 Elsevier Ltd. All rights reserved.
PY - 2023/11
Y1 - 2023/11
N2 - Surgical resection represents the standard of care for people with newly diagnosed diffuse gliomas, and the neuropathological and molecular profile of the resected tissue guides clinical management and forms the basis for research. The Response Assessment in Neuro-Oncology (RANO) consortium is an international, multidisciplinary effort that aims to standardise research practice in neuro-oncology. These recommendations represent a multidisciplinary consensus from the four RANO groups: RANO resect, RANO recurrent glioblastoma, RANO radiotherapy, and RANO/PET for a standardised workflow to achieve a representative tumour evaluation in a disease characterised by intratumoural heterogeneity, including recommendations on which tumour regions should be surgically sampled, how to define those regions on the basis of preoperative imaging, and the optimal sample volume. Practical recommendations for tissue sampling are given for people with low-grade and high-grade gliomas, as well as for people with newly diagnosed and recurrent disease. Sampling of liquid biopsies is also addressed. A standardised workflow for subsequent handling of the resected tissue is proposed to avoid information loss due to decreasing tissue quality or insufficient clinical information. The recommendations offer a framework for prospective biobanking studies.
AB - Surgical resection represents the standard of care for people with newly diagnosed diffuse gliomas, and the neuropathological and molecular profile of the resected tissue guides clinical management and forms the basis for research. The Response Assessment in Neuro-Oncology (RANO) consortium is an international, multidisciplinary effort that aims to standardise research practice in neuro-oncology. These recommendations represent a multidisciplinary consensus from the four RANO groups: RANO resect, RANO recurrent glioblastoma, RANO radiotherapy, and RANO/PET for a standardised workflow to achieve a representative tumour evaluation in a disease characterised by intratumoural heterogeneity, including recommendations on which tumour regions should be surgically sampled, how to define those regions on the basis of preoperative imaging, and the optimal sample volume. Practical recommendations for tissue sampling are given for people with low-grade and high-grade gliomas, as well as for people with newly diagnosed and recurrent disease. Sampling of liquid biopsies is also addressed. A standardised workflow for subsequent handling of the resected tissue is proposed to avoid information loss due to decreasing tissue quality or insufficient clinical information. The recommendations offer a framework for prospective biobanking studies.
KW - Humans
KW - Brain Neoplasms/diagnostic imaging
KW - Prospective Studies
KW - Biological Specimen Banks
KW - Neoplasm Recurrence, Local/surgery
KW - Glioma/diagnostic imaging
U2 - 10.1016/S1470-2045(23)00453-9
DO - 10.1016/S1470-2045(23)00453-9
M3 - SCORING: Review article
C2 - 37922934
VL - 24
SP - e438-e450
JO - LANCET ONCOL
JF - LANCET ONCOL
SN - 1470-2045
IS - 11
ER -